Provided by Tiger Trade Technology Pte. Ltd.

Merck

122.26
+0.40000.33%
Post-market: 122.430.1700+0.14%19:26 EST
Volume:9.44M
Turnover:1.15B
Market Cap:303.45B
PE:16.79
High:122.70
Open:122.64
Low:120.60
Close:121.86
52wk High:123.33
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:0.94
T/O Rate:0.38%
Dividend:3.28
Dividend Rate:2.68%
EPS(TTM):7.28
EPS(LYR):7.28
ROE:37.17%
ROA:13.76%
PB:5.85
PE(LYR):16.79

Loading ...

Moderna and Merck Advance mRNA Cancer Vaccine Trial in First-Line Lung Cancer: What Investors Should Watch

TIPRANKS
·
7 hours ago

Merck Initiated at Overweight by Barclays

Dow Jones
·
Yesterday

Barclays Initiates Coverage on Merck With Overweight Rating

MT Newswires Live
·
Yesterday

U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler

Reuters
·
Yesterday

Merck initiated with an Overweight at Barclays

TIPRANKS
·
Yesterday

Is It Too Late To Consider Merck (MRK) After Its Strong Multi Year Share Price Run?

Simply Wall St.
·
Yesterday

Merck Says New Phase 3 Data Indicate Stable Safety Profile for Enflonsia

MT Newswires Live
·
Feb 19

Merck announces new Enflonsia data from SMART trial

TIPRANKS
·
Feb 19

Merck reports positive Phase 3 SMART trial data for ENFLONSIA in high-risk children under 2 across two RSV seasons

Reuters
·
Feb 19

Merck & Co Inc - Smart Trial Data Shows Consistent Safety for Enflonsia

THOMSON REUTERS
·
Feb 19

Merck Announces Positive New Data for Enflonsia™ (Clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (Rsv) Disease Over Two Rsv Seasons

THOMSON REUTERS
·
Feb 19

Merck, Mayo Clinic announce new R&D collaboration

TIPRANKS
·
Feb 18

Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine

THOMSON REUTERS
·
Feb 18

Merck and Mayo Clinic Form AI-Driven Drug Discovery Collaboration

Reuters
·
Feb 18

EXCLUSIVE-California preparing lawsuit over Trump administration vaccine changes

Reuters
·
Feb 18

Top News Today/Canada: Inflation Cooled a Bit in January

Dow Jones
·
Feb 18

Merck announces Health Canada approval of KEYTRUDA SC

TIPRANKS
·
Feb 18

BRIEF-Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell

Reuters
·
Feb 18

Health Canada Approves Merck's Subcutaneous KEYTRUDA for Multiple Cancers

Reuters
·
Feb 18

Health Canada Approves Keytruda Sc™, a Subcutaneous Formulation of Pembrolizumab Across Multiple Cancer Indications

THOMSON REUTERS
·
Feb 18